Neuropsychiatric Outcomes With Tirzepatide, Semaglutide, and Other GLP-1 Receptor Agonists [PMID: 42420795] Laboratory literature summary: Neuropsychiatric Outcomes With Tirzepatide, Semaglutide, and Other GLP-1 Receptor Agonists
Diabetes Self-Management Education Patients with T2DM should receive proper education on all aspects of their diabetes management
Weight reduction is often associated with decreased blood pressure, improved cholesterol levels, and reduced systemic inflammationall of which contribute to a lower risk of heart disease
A landmark crossover study utilizing Magnetic Resonance Imaging (MRI) meticulously assessed muscle disruption following a heavy physical exertion protocol
Most of these symptoms can be minimized with adequate hydration, electrolyte replacement and vitamins
Statistical analyses were performed using MATLAB version 2020a, and all P values were two-sided